Navigation Links
Dr. David Slaughter Launches Groundbreaking Cavity Prevention Program That Can Lower Decay Rates by 74%
Date:3/6/2013

(PRWEB) March 06, 2013

Dental decay is the number 1 chronic disease affecting American youth; surpassing both obesity and asthma. For Dr. David Slaughter and his team those statistics are no longer daunting. They have taken the top caries research in the world and implemented a cavity prevention program developed by CariFree that is shown to decrease incidents of tooth decay by up to 74%. The system is known as CAMBRA or Caries Management by Risk Assessment. It has been especially helpful for patients who take several medications, have dry mouth, and have new decay frequently.

CAMBRA is rooted in a medical model of risk assessment. It requires the dental professional to assess each and every patient’s risk factors for the disease and then develop a personalized treatment plan to systematically lower their risk. The CariFree diagnostic tools leverage biofilm testing (to determine the levels of cavity-causing bacteria in the patient’s mouth) as well as a risk assessment questionnaire to determine the overall statistical probability a patient will develop new cavities over the next 12 months. Never before has such predictive information been available. Patients can then measurably lower their risk for decay by utilizing professional products and behavior modification. Dr. Slaughter says: "This is not just great for caries, but has done amazing things to stop sensitivity for my patients. I do not condone it, but one patient even canceled her tissue graft surgery!"

Patients can expect the entire process to take a few minutes in their appointment. They will answer targeted questions regarding their current habits (eating and drinking, medication use, chronic health issues etc.) as well as undergo a quick, painless swab of their lower teeth (to determine if they have an excess of cavity causing bacteria). The quick and painless test can even be done by the hygienist before a routine cleaning appointment. Then based on the information gathered, their dental team will counsel them on an appropriate course of action to lower their risk. If professional products are recommended the practitioner will provide the patient with a professional kit of product specifically designed to counteract their risk factors.

The CariFree products contain all 5 essential therapeutic agents proven to treat dental caries. Depending on the patients diagnosis the proper level of therapy will be prescribed. Science has proven that this disease cannot be stopped by the drill and fill approach. True cure requires a medical approach and a comprehensive assessment of each patient. Dr. Slaughter has taken a bold and caring step for their patients and their community.

For more information on the CariFree system go to http://www.carifree.com. To call now and make your appointment with Dr.Slaughter and his team call 512-258-2233.

About Dr. Slaughter: Dr. Slaughter has long been interested in dentistry, as he had a good amount of personal experience undergoing treatments as a young person, including many trips to the dentist, oral surgeon, and orthodontist. During his high school years, he volunteered in dental offices to gain more knowledge of the field, went on to earn his BA in Biology from West Texas State University, then pursued his Doctorate of Dental Surgery at the University of Texas Dental Branch. During his time in dental school, he served as school representative for the American Association of Dental Schools. He served as co-chairman of the Capital Area Dental Society's Young Dentist Committee from 2003 to 2005 and is actively involved with the Central Texas Academy of General Dentistry and the Capital Area Dental Society. Dr. Slaughter has done advanced study in occlusion at the Kois Center in Seattle, implants with Nobel BioCare of Loma Linda, California and attends several courses yearly studying esthetics and restorative dentistry. Dr. Slaughterhas been named to the Super Dentists list published in a special section in Texas Monthly for three consecutive years.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10493863.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
2. David Smith Named Vice President of Operations for HealthTell
3. DuPont Congratulates David Hula for Highest Overall Yield with Pioneer® hybrid – P2088YHR in 2012 NCGA Corn Yield Contest
4. David Lichtenstein: Biotechnology is Rich Area for Investment
5. Renowned Operations and Supply Chain Expert Dr. David Simchi-Levi Joins OPS Rules
6. Maine Center for Creativity Selects Glenn Close and David Shaw to Receive Inaugural Maine Creative Industry Award
7. China Biologic Products Names Chairman David Gao to Additional Post of CEO
8. Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Inergetics Advisory Board to Co-Develop and Market Products to Penetrate Nephrology Market
9. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
10. HDI Launches New More Economical Lab ShockWave Power Cavitation Reactor
11. Bayer CropScience Launches Bee Care Tour in Corn Belt States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):